Analyst Research

Report Title Price
Thomson Reuters Stock Report - OCLARO, INCORPORATION (OCLR-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Oclaro, Inc. (OCLR) - Medical Equipment - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
OCLARO INC (OCLR) Zacks Company Snapshot
Provider: Zacks Investment Research Inc.
$12.00
Buy
OCLARO INC (OCLR) Zacks Company Snapshot
Provider: Zacks Investment Research Inc.
$12.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Oclaro, Inc. And Opnext, Inc. Completes Merger


Tuesday, 24 Jul 2012 08:03am EDT 

Oclaro, Inc. and Opnext, Inc. announced shareholder approval of their merger, which closed July 23, 2012. The combined company will continue to operate under the Oclaro name, and unveiled a new logo and brand identity. Opnext shareholders will receive a fixed ratio of 0.42 shares of Oclaro common stock for every share of Opnext common stock they own. 

Latest Developments for Oclaro Inc

Latest Key Developments in Medical

Company Quote

Oclaro Inc
(OCLR.OQ)
1.09
0.0 +0.00%
23 May 2013